U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H17N4OS.NO3
Molecular Weight 327.361
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THIAMINE MONONITRATE

SMILES

Cc1c(CCO)sc[n+]1Cc2cnc(C)[nH]c2=N.N(=O)(=O)[O-]

InChI

InChIKey=UIERGBJEBXXIGO-UHFFFAOYSA-N
InChI=1S/C12H17N4OS.NO3/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;2-1(3)4/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);/q+1;-1

HIDE SMILES / InChI

Molecular Formula C12H17N4OS
Molecular Weight 265.3561
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula NO3
Molecular Weight 62.0049
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Thiamine, also known as vitamin B1, plays a key role in the human metabolism. It is present in many dietary sources such as meats, eggs, fish, beans and peas, nuts, and whole grains. Upon administration thiamine is converted by thiamine pyrophosphokinase-1 (TPK1) to the active form, thiamine pyrophosphate, which serves as a cofactor for enzymes involved in the TCA cycle and the non-oxidative part of the pentose phosphate pathway. The lack of thiamine may cause the thiamine deficiency. The classical syndrome caused primarily by thiamine deficiency in humans is beriberi, however, symptoms of thiamine deficiency also include congestive heart failure, metabolic acidosis, confusion, ataxia and seizures. Thiamine is a component of many vitamin complexes, which are approved for the treatmen and prevention of general vitamin deficiency, including the thiamine deficiency.

CNS Activity

Curator's Comment:: The transport of thiamine across the blood brain barrier was shown in rats.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q9H3S4
Gene ID: 27010.0
Gene Symbol: TPK1
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
M.V.I.-12

Approved Use

M.V.I.-12 Unit Vial, is indicated for the prevention of vitamin deficiency in adults and children aged 11 years and above who are on warfarin anticoagulant therapy receiving home parenteral nutrition.

Launch Date

-5.32137607E11
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
386 nM
1500 mg single, oral
dose: 1500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
40 nM
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
95 nM
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
39 nM
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
397 nM
1500 mg single, oral
dose: 1500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
113 nM
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
2046 nM × h
1500 mg single, oral
dose: 1500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
214 nM × h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
623 nM × h
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
177 nM × h
100 mg single, oral
dose: 100 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
2059 nM × h
1500 mg single, oral
dose: 1500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
612 nM × h
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
4.78 h
1500 mg single, oral
dose: 1500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
2.97 h
1500 mg single, oral
dose: 1500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
3.92 h
500 mg single, oral
dose: 500 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
THIAMINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
Doses

Doses

DosePopulationAdverse events​
500 mg single, intravenous
Highest studied dose
Dose: 500 mg
Route: intravenous
Route: single
Dose: 500 mg
Sources:
unhealthy, adult
n = 19
Health Status: unhealthy
Condition: various patients
Age Group: adult
Sex: unknown
Population Size: 19
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer




Drug as perpetrator​Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
yes
PubMed

PubMed

TitleDatePubMed
Thiamine for Alzheimer's disease.
2001
[Evaluation of vitamin and immune status of patients with chronic palatal tonsillitis].
2001
Effects of vitamins on hepatic nuclear binding of L-tryptophan.
2001
Rapid diagnosis of alcoholic ketoacidosis by proton NMR.
2001 Apr
Severe metabolic acidosis and heart failure due to thiamine deficiency.
2001 Apr
Do breastfed infants need supplemental vitamins?
2001 Apr
Conditioned nutritional deficiencies in the cardiomyopathic hamster heart.
2001 Apr
Nutritional evaluation of ethanol-extracted lentil flours.
2001 Apr
[Chronic alcohol abuse. Benfotiamine in alcohol damage is a must].
2001 Apr 19
Consequences of a modified putative substrate-activation site on catalysis by yeast pyruvate decarboxylase.
2001 Feb 13
Inhibitors of advanced glycation end product-associated protein cross-linking.
2001 Feb 14
Reaction mechanism for mammalian pyruvate dehydrogenase using natural lipoyl domain substrates.
2001 Feb 15
Molecular cloning of human thiamin pyrophosphokinase.
2001 Jan 26
Isolation and characterization of a human thiamine pyrophosphokinase cDNA.
2001 Jan 26
Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.
2001 Jan-Feb
Marginal vitamin and mineral intake of Costa Rican adolescents.
2001 Jan-Feb
Use of vitamin supplements and cataract: the Blue Mountains Eye Study.
2001 Jul
Low thiamine intake and risk of cataract.
2001 Jul
Mechanism of thiamine uptake by human colonocytes: studies with cultured colonic epithelial cell line NCM460.
2001 Jul
Sulphoacetaldehyde sulpho-lyase (EC 4.4.1.12) from Desulfonispora thiosulfatigenes: purification, properties and primary sequence.
2001 Jul 15
No association between DLST gene and Alzheimer's disease or Wernicke-Korsakoff syndrome.
2001 Jul-Aug
The crystal structure of yeast thiamin pyrophosphokinase.
2001 Jun
Vitamin B intake and status in healthy Havanan men, 2 years after the Cuban neuropathy epidemic.
2001 Jun
Nutritional status in elderly female hip fracture patients: comparison with an age-matched home living group attending day centres.
2001 Jun
Vitamin B1 and B6 retention in milk after continuous-flow microwave and conventional heating at high temperatures.
2001 Jun
Slc19a2: cloning and characterization of the murine thiamin transporter cDNA and genomic sequence, the orthologue of the human TRMA gene.
2001 Jun
Simultaneous determination of thiamine and pyridoxine in pharmaceuticals by using a single flow-through biparameter sensor.
2001 Jun
Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART.
2001 Jun
Chronic heart failure and micronutrients.
2001 Jun 1
Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status.
2001 Jun 26
Catalytic acid-base groups in yeast pyruvate decarboxylase. 1. Site-directed mutagenesis and steady-state kinetic studies on the enzyme with the D28A, H114F, H115F, and E477Q substitutions.
2001 Jun 26
Relationships between dietary intake and cognitive function level in Korean elderly people.
2001 Mar
Wernicke's encephalopathy in patients with hyperemesis gravidarum.
2001 Mar
[Shoshin beriberi: myth or reality?].
2001 Mar
Simultaneous determination of thiamin and riboflavin in mushrooms by liquid chromatography.
2001 Mar
Thiamine treatment of chronic hepatitis B infection.
2001 Mar
The genes for anabolic 2-oxoglutarate: ferredoxin oxidoreductase from Hydrogenobacter thermophilus TK-6.
2001 Mar 30
[Metabolic characteristics of the Yarrowia lipolytica strain producing alpha-ketoglutaric and citric acids from ethanol and the effect of [NH4+] and [O2] on yeast respiration and biosynthesis].
2001 Mar-Apr
[Isolation, purification and properties of acetolactate synthase from cultured Lactococcus lactis].
2001 Mar-Apr
[Other drugs administered with TPN solution].
2001 May
[Metabolic acidosis induced by TPN].
2001 May
[Solutions for the hyperalimentation].
2001 May
Pharmacotherapy of mental illness--a historical analysis.
2001 May
Biogenic amine metabolites and thiamine in cerebrospinal fluid in heredo-degenerative ataxias.
2001 May
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.
2001 May
Early recognition of acute cardiovascular beriberi by interpretation of hemodynamics.
2001 May
Wernicke's encephalopathy in a non-alcoholic man: case report and brief review.
2001 May
Stability of thiamine and vitamins E and A during storage of enteral feeding formula.
2001 May
The bio operon on the acquired symbiosis island of Mesorhizobium sp. strain R7A includes a novel gene involved in pimeloyl-CoA synthesis.
2001 May
The role of the cysteine residues of ThiI in the generation of 4-thiouridine in tRNA.
2001 Sep 7
Patents

Sample Use Guides

The starting dose (as a component of M.V.I.–12) is one 10 mL daily dose added directly to an intravenous fluid.
Route of Administration: Intravenous
Human Caco-2 cells were incubated (37 Celsius) in Krebs-Ringer buffer (pH 7.4) for different periods of time in the presence of 0.1 uM and 10 uM thiamine. The uptake study demonstrated that thiamine is transported across the cell membrane with Michaelis-Menten constant of 3.18 uM.
Substance Class Chemical
Created
by admin
on Fri Jun 25 21:12:16 UTC 2021
Edited
by admin
on Fri Jun 25 21:12:16 UTC 2021
Record UNII
8K0I04919X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
THIAMINE MONONITRATE
FCC   MI   USP   VANDF   WHO-DD   WHO-IP  
Common Name English
THIAMINE MONONITRATE [USP]
Common Name English
THIAMINE NITRATE [INCI]
Common Name English
THIAMINE NITRATE [MART.]
Common Name English
ANEURINE MONONITRATE
Common Name English
THIAMINE NITRATE [EP MONOGRAPH]
Common Name English
THIAMINE NITRATE (SALT)
WHO-IP  
Common Name English
THIAMIN MONONITRATE
Common Name English
VITAMIN B1 MONONITRATE
Common Name English
THIAMINE MONONITRATE [MI]
Common Name English
THIAMINE MONONITRATE [WHO-IP]
Common Name English
THIAMINI MONONITRAS [WHO-IP LATIN]
Common Name English
THIAMINE NITRATE [EP]
Common Name English
THIAMINE NITRATE (SALT) [WHO-IP]
Common Name English
BETABION MONONITRATE
Common Name English
THIAMINE MONONITRATE [FCC]
Common Name English
THIAMINE NITRATE
EP   INCI   MART.  
INCI  
Official Name English
THIAZOLIUM, 3-((4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL)-5-(2-HYDROXYETHYL)-4-METHYL-, NITRATE (SALT)
Common Name English
VITAMIN B1 (AS THIAMINE NITRATE)
Common Name English
THIAMINE MONONITRATE [VANDF]
Common Name English
Classification Tree Code System Code
DSLD 2833 (Number of products:2062)
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
CFR 21 CFR 184.1878
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
NCI_THESAURUS C45812
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
Code System Code Type Description
WHO INTERNATIONAL PHARMACOPEIA
THIAMINE MONONITRATE
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY Description: Colourless crystals or a white, crystalline powder; odour, slight and characteristic. Solubility: Sparingly soluble in water; very slightly soluble in ethanol (~750 g/l) TS. Category: Component of vitamin B. Storage: Thiamine mononitrate should be kept in a tightly closed, non-metallic container, protected from light. Additional information: Even in the absence of light, Thiamine mononitrate is gradually degraded on exposure to a humidatmosphere, the decomposition being faster at higher temperatures. Definition: Thiamine mononitrate contains not less than 98.0% and not more than 101.0% of C12H17N5O4S, calculated with reference to the dried substance.
FDA UNII
8K0I04919X
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
RXCUI
10456
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY RxNorm
PUBCHEM
10762
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
DRUG BANK
DBSALT001495
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
ChEMBL
CHEMBL1547
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
ECHA (EC/EINECS)
208-537-4
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
CAS
532-43-4
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
EVMPD
SUB12366MIG
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
MERCK INDEX
M10717
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY Merck Index
NCI_THESAURUS
C87669
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
EPA CompTox
532-43-4
Created by admin on Fri Jun 25 21:12:16 UTC 2021 , Edited by admin on Fri Jun 25 21:12:16 UTC 2021
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY